Quarterly report pursuant to Section 13 or 15(d)

CONDENSED INTERIM STATEMENTS OF CHANGES IN MEMBERS' AND SHAREHOLDERS' EQUITY

v3.22.2.2
CONDENSED INTERIM STATEMENTS OF CHANGES IN MEMBERS' AND SHAREHOLDERS' EQUITY - USD ($)
Membership Interest
Members' Equity, Class A
Membership Interest
Members' Equity, Class B
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2020 $ 16,402,198 $ 100,000     $ (13,800,612) $ 2,701,586
Balance at beginning, Member Units (in shares) at Dec. 31, 2020 13,493,807 100,000        
Executive Compensation Settled with Membership Interests $ 186,650 $ 730,115       916,765
Executive Compensation Settled with Membership Interests (in shares) 57,430 471,042        
Cancellation of Class B Issuance (in shares)   (471,042)        
Share-Based Compensation $ 191,667         191,667
Share-Based Compensation, (in shares) 143,814          
Share-Based Payments to Vendors $ 135,471         135,471
Share-Based Payments to Vendors (in shares) 30,145          
Net Loss         (1,474,330) (1,474,330)
Balance at ending at Mar. 31, 2021 $ 16,915,986 $ 830,115     (15,274,942) 2,471,159
Balance at ending, Member Units (in shares) at Mar. 31, 2021 13,725,196 100,000        
Balance at beginning at Dec. 31, 2020 $ 16,402,198 $ 100,000     (13,800,612) 2,701,586
Balance at beginning, Member Units (in shares) at Dec. 31, 2020 13,493,807 100,000        
Net Loss           (10,120,611)
Balance at ending at Sep. 30, 2021     $ 10,127 $ 38,188,287 (23,921,223) 14,277,191
Balance at ending, Common shares (in shares) at Sep. 30, 2021     10,126,903      
Balance at beginning at Mar. 31, 2021 $ 16,915,986 $ 830,115     (15,274,942) 2,471,159
Balance at beginning, Member Units (in shares) at Mar. 31, 2021 13,725,196 100,000        
Share-Based Compensation $ 563,889     1,655,885   2,219,774
Share-Based Compensation, (in shares) 257,122          
Share-Based Payments to Vendors $ 37,500         37,500
Corporate Conversion $ (17,517,375) $ (830,115) $ 7,041 18,340,449    
Corporate Conversion (in shares) (13,982,318) (100,000) 7,041,208      
Issuance of shares of common stock and pre-funded warrants in registered direct offering, net of cash issuance costs     $ 2,875 14,794,257   14,797,132
Initial Public Offering and underwriter warrants, net of cash issuance costs (in shares)     2,875,000      
Net Loss         (4,004,059) (4,004,059)
Balance at ending at Jun. 30, 2021     $ 9,916 34,790,591 (19,279,001) 15,521,506
Balance at ending, Common shares (in shares) at Jun. 30, 2021     9,916,208      
Share-Based Compensation       2,070,637   2,070,637
Share-Based Payments to Vendors     $ 211 1,327,059   1,327,270
Share-Based Payments to Vendors (in shares)     210,695      
Net Loss         (4,642,222) (4,642,222)
Balance at ending at Sep. 30, 2021     $ 10,127 38,188,287 (23,921,223) 14,277,191
Balance at ending, Common shares (in shares) at Sep. 30, 2021     10,126,903      
Balance at beginning at Dec. 31, 2021     $ 10,216 38,948,334 (26,548,309) $ 12,410,241
Balance at beginning, Common shares (in shares) at Dec. 31, 2021     10,215,792     10,215,792
Share-Based Compensation       761,069   $ 761,069
Share-Based Payments to Vendors     $ 44 188,056   188,100
Share-Based Payments to Vendors (in shares)     43,889      
Cashless Warrant Exercise     $ 3 (3)    
Cashless Warrant Exercise (in shares)     3,521      
Net Loss         (2,670,138) (2,670,138)
Balance at ending at Mar. 31, 2022     $ 10,263 39,897,456 (29,218,447) 10,689,272
Balance at ending, Common shares (in shares) at Mar. 31, 2022     10,263,202      
Balance at beginning at Dec. 31, 2021     $ 10,216 38,948,334 (26,548,309) $ 12,410,241
Balance at beginning, Common shares (in shares) at Dec. 31, 2021     10,215,792     10,215,792
Net Loss           $ (8,832,265)
Balance at ending at Sep. 30, 2022     $ 11,593 45,132,049 (35,380,574) $ 9,763,068
Balance at ending, Common shares (in shares) at Sep. 30, 2022     11,592,609     11,592,609
Balance at beginning at Mar. 31, 2022     $ 10,263 39,897,456 (29,218,447) $ 10,689,272
Balance at beginning, Common shares (in shares) at Mar. 31, 2022     10,263,202      
Share-Based Compensation       716,682   716,682
Net Loss         (2,620,533) (2,620,533)
Balance at ending at Jun. 30, 2022     $ 10,263 40,614,138 (31,838,980) 8,785,421
Balance at ending, Common shares (in shares) at Jun. 30, 2022     10,263,202      
Share-Based Compensation       696,965   696,965
Share-Based Payments to Vendors     $ 36 127,044   127,080
Share-Based Payments to Vendors (in shares)     36,000      
Cashless Warrant Exercise     $ 4 (4)    
Cashless Warrant Exercise (in shares)     3,427      
Pre-funded Warrant Exercise     $ 131 (118)   13
Pre-funded Warrant Exercise (in shares)     130,769      
Issuance of shares of common stock and pre-funded warrants in registered direct offering, net of cash issuance costs     $ 1,159 3,694,024   3,695,183
Initial Public Offering and underwriter warrants, net of cash issuance costs (in shares)     1,159,211      
Net Loss         (3,541,594) (3,541,594)
Balance at ending at Sep. 30, 2022     $ 11,593 $ 45,132,049 $ (35,380,574) $ 9,763,068
Balance at ending, Common shares (in shares) at Sep. 30, 2022     11,592,609     11,592,609